Convatec updates 2023 outlook: Higher organic growth, maintains EBIT margin guidance
British medical device company Convatec has raised the lower end of its organic growth guidance for 2023.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.